Back to top

earnings-estimates-revisions: Archive

Swayta Shah

Is SNEX Stock Worth Buying After Its Sharp Run and Richer Valuation?

StoneX's record results and acquisition gains support the bull case, but its sharp rally and richer valuation make clean execution crucial.

CMENegative Net Change IBKRPositive Net Change SNEXNegative Net Change

Urmimala Biswas

Is QBTS the NVIDIA of Quantum Computing or is it Overvalued?

QBTS is drawing comparisons to NVIDIA as D-Wave expands its quantum ambitions, but a rich valuation raises the stakes for future execution.

NVDANegative Net Change QBTSNegative Net Change

Zacks Equity Research

Harmony Gold (HMY) Upgraded to Buy: Here's What You Should Know

Harmony Gold (HMY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

HMYPositive Net Change

Zacks Equity Research

Yeti (YETI) Upgraded to Buy: Here's What You Should Know

Yeti (YETI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

YETINegative Net Change

Zacks Equity Research

Pan American Silver (PAAS) Upgraded to Buy: What Does It Mean for the Stock?

Pan American Silver (PAAS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

PAASPositive Net Change

Zacks Equity Research

Wave Life Sciences (WVE) Upgraded to Buy: Here's Why

Wave Life Sciences (WVE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

WVENegative Net Change

Zacks Equity Research

MSCI (MSCI) Upgraded to Buy: What Does It Mean for the Stock?

MSCI (MSCI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

MSCINegative Net Change

Zacks Equity Research

Kiniksa Pharmaceuticals International, plc (KNSA) Upgraded to Strong Buy: Here's What You Should Know

Kiniksa Pharmaceuticals International, plc (KNSA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

KNSANegative Net Change

Zacks Equity Research

Gerdau (GGB) Upgraded to Buy: Here's What You Should Know

Gerdau (GGB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

GGBNegative Net Change

Zacks Equity Research

Everus Construction Group, Inc. (ECG) Upgraded to Strong Buy: Here's Why

Everus Construction Group, Inc. (ECG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

ECGNegative Net Change